Patent · US Active

In-vitro cardiopulmonary combined perfusion system and perfusion method

US11425901B2 · kind B2 · utility

0Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 27, 2021
Grant dateAug 30, 2022
Priority date
Expiry dateAug 27, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2202/0476
  • WIPO fieldBasic materials chemistry
  • WIPO sectorChemistry

Abstract

Disclosed are an in-vitro cardiopulmonary combined perfusion system and perfusion method. The in-vitro cardiopulmonary combined perfusion system includes an organ cabin, a circulation cabin, a control cabin, a simple breathing cabin, a display and control panel, and a base. The organ cabin is connected with the circulation cabin, the control cabin and the simple breathing cabin. The control cabin is connected with the display and control panel. The organ cabin, the circulation cabin, the control cabin, the simple breathing cabin, and the display and control panel are mounted on the base.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.